Absci Corporation
Healthcare · Biotechnology
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
66
Total Trades
66
Buy Orders
14.42M shares
0
Sell Orders
0.00M shares
+14.42M
Net Position
| Date | Type | Fund | Shares | % of Fund |
|---|---|---|---|---|
| Nov 13 | Buy | ARKG | 421,480 | 0.093% |
| Jul 25 | Buy | ARKG | 2,248,226 | 0.598% |
| Mar 25 | Buy | ARKG | 70,081 | 0.019% |
| Mar 24 | Buy | ARKG | 27,493 | 0.008% |
| Mar 21 | Buy | ARKG | 71,392 | 0.020% |
| Mar 20 | Buy | ARKG | 298,652 | 0.084% |
| Mar 19 | Buy | ARKG | 436,880 | 0.121% |
| Mar 11 | Buy | ARKG | 34,441 | 0.009% |
| Mar 10 | Buy | ARKG | 76,539 | 0.020% |
| Mar 7 | Buy | ARKG | 50,102 | 0.013% |
| Mar 6 | Buy | ARKG | 122,649 | 0.032% |
| Feb 26 | Buy | ARKG | 75,340 | 0.026% |
| Feb 25 | Buy | ARKG | 97,505 | 0.031% |
| Feb 3 | Buy | ARKG | 30,091 | 0.009% |
| Jan 28 | Buy | ARKG | 69,250 | 0.021% |
| Jan 23 | Buy | ARKG | 20,310 | 0.006% |
| Jan 22 | Buy | ARKG | 5,053 | 0.002% |
| Jan 21 | Buy | ARKG | 79,411 | 0.023% |
| Jan 8 | Buy | ARKG | 608,900 | 0.181% |
| Date | Type | Fund | Shares | % of Fund |
|---|---|---|---|---|
| Dec 5 | Buy | ARKG | 202,581 | 0.048% |
| Dec 3 | Buy | ARKG | 400,323 | 0.092% |
| Dec 2 | Buy | ARKG | 99,784 | 0.025% |
| Nov 26 | Buy | ARKG | 167,516 | 0.038% |
| Nov 25 | Buy | ARKG | 34,623 | 0.008% |
| Nov 7 | Buy | ARKG | 94,351 | 0.029% |
| Nov 6 | Buy | ARKG | 231,971 | 0.075% |
| Oct 31 | Buy | ARKG | 150,006 | 0.048% |
| Oct 30 | Buy | ARKG | 401,329 | 0.134% |
| Oct 29 | Buy | ARKG | 446,810 | 0.149% |
| Oct 28 | Buy | ARKG | 486,699 | 0.172% |
| Sep 16 | Buy | ARKG | 69,303 | 0.020% |
| Sep 13 | Buy | ARKG | 920 | 0.000% |
| Sep 12 | Buy | ARKG | 15,182 | 0.004% |
| Sep 11 | Buy | ARKG | 70,643 | 0.020% |
| Sep 10 | Buy | ARKG | 212,034 | 0.058% |
| Sep 3 | Buy | ARKG | 30,672 | 0.009% |
| Aug 30 | Buy | ARKG | 27,013 | 0.008% |
| Aug 29 | Buy | ARKG | 19,191 | 0.006% |
| Aug 28 | Buy | ARKG | 82,669 | 0.025% |
| Aug 26 | Buy | ARKG | 10,833 | 0.003% |
| Aug 22 | Buy | ARKG | 228,629 | 0.068% |
| Aug 21 | Buy | ARKG | 3,510 | 0.001% |
| Aug 20 | Buy | ARKG | 36,874 | 0.011% |
| Aug 19 | Buy | ARKG | 6,231 | 0.002% |
| Aug 6 | Buy | ARKG | 398 | 0.000% |
| Aug 5 | Buy | ARKG | 42,849 | 0.011% |
| Jul 5 | Buy | ARKG | 12,566 | 0.003% |
| Jul 2 | Buy | ARKG | 113,743 | 0.027% |
| Jul 1 | Buy | ARKG | 109,306 | 0.026% |
| Jun 28 | Buy | ARKG | 143,573 | 0.034% |
| Jun 27 | Buy | ARKG | 144,505 | 0.034% |
| Jun 26 | Buy | ARKG | 78,693 | 0.018% |
| Jun 25 | Buy | ARKG | 222,314 | 0.050% |
| Jun 21 | Buy | ARKG | 290,516 | 0.064% |
| Jun 20 | Buy | ARKG | 261,881 | 0.059% |
| Jun 18 | Buy | ARKG | 147,369 | 0.037% |
| Jun 17 | Buy | ARKG | 152,843 | 0.036% |
| May 31 | Buy | ARKG | 64,231 | 0.020% |
| May 30 | Buy | ARKG | 144,787 | 0.045% |
| May 29 | Buy | ARKG | 375,779 | 0.109% |
| May 28 | Buy | ARKG | 239,888 | 0.072% |
| Feb 28 | Buy | ARKG | 2,989,186 | 0.690% |
| Feb 5 | Buy | ARKG | 14,270 | 0.003% |
| Jan 11 | Buy | ARKG | 249,878 | 0.048% |
| Jan 10 | Buy | ARKG | 68,007 | 0.013% |
| Jan 9 | Buy | ARKG | 177,027 | 0.033% |